Peter Powers

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis

Mark Levine, Michael Gent, Jack Hirsh et al. · New England Journal of Medicine · 1996 · 1.2K citations · Full text

Medicine, Hematology, Pharmacology +17

Development of the human coagulation system in the full-term infant

M Andrew, Bosco Paes, Ruth Milner et al. · Blood · 1987 · 1.2K citations · Full text

Medicine, Pediatrics, Physiology +14

Development of the human coagulation system in the healthy premature infant

M Andrew, Bosco Paes, Ruth Milner et al. · Blood · 1988 · 734 citations · Full text

Medicine, Pediatrics, Physiology +14

A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery

Alexander G.G. Turpie, Mark Levine, Jack Hirsh et al. · New England Journal of Medicine · 1986 · 527 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17